A report from the journal of Translational Vision Science & Technology has highlighted a recent symposium for advancing clinical trials for Inherited Retinal Diseases (IRDs). … Read More »A report has provided key 7 recommendations from a retinal symposium for advancing clinical trials for Inherited Retinal Diseases (IRDs)
Family organisations and the Foundation Fighting Blindness have published a new report on an initiative outlining a model for how affected individuals and their families… Read More »A report on a workshop for accelerating the development of treatments for inherited retinal degenerations (IRDs).
Researchers at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK, have reported the largest series and longitudinal study results in sector retinitis pigmentosa,… Read More »Research on sectoral retinitis pigmentosa (RP) has identified a broad spectrum of genes and natural history.
Researchers in the Institute of Molecular and Clinical Ophthalmology Basel, Switzerland have reported a novel strategy to use near-infrared (NIR) wavelength inputs to restore blind… Read More »Innovative approach aims to use near-infrared to convert light into heat through an engineered channel to restore retina sensitivity
A research study on genetic diagnosis testing for biallelic RP1 has found a broad spectrum of retinal disease identifying the largest reported group of unrelated… Read More »Biallelic RP1 study has expanded the mutational and clinical spectrum of retinitis pigmentosa.
A research study on genetic diagnostic testing found that many patients did not undergo testing due to the cost of genetic testing. In addition, other… Read More »Rates of diagnostic genetic testing linked to significant costs as a main reason to avoid testing.
A research group, based at the Massachusetts Eye and Ear, Harvard Medical School, Boston, and Oregon Health & Science University, Portland, has published a new… Read More »RP-1 associated with retinal dystrophies have been reported in an expanding mutational and clinical spectrum.
A collaborative research group with scientists working in Ireland, France, USA and Canada has reported the effects of single 7-day oral retinoid supplementation lasting “at… Read More »Proof-of-concept study for oral synthetic 9 cis-retinyl provides visual rescue for late-onset autosomal dominant retinitis pigmentosa (adRP)
A new bibliometric report on randomised controlled trials (RCTs) of ophthalmology has clearly identified that retinal disease had the highest number of RCTs over a… Read More »Randomised controlled trials (RCTs) in ophthalmology shows that retinal disease research leads with the highest number of studies
A new research study, published in the journal JAMA Ophthalmology, suggests that a dose of 0.004mg bevacizumab may be the lowest dose effective for retinopathy… Read More »Results of a dose-finding bevacizumab (Avastin) study for ROP may be effective for pre-term infants